Aurora Cannabis (ACB) Cost of Revenue (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Cost of Revenue of $6.0 million for Q1 2026, down 90.36% year-over-year from $62.2 million in Q1 2025, and down 82.58% quarter-over-quarter from $34.4 million in Q4 2025.
Aurora Cannabis (ACB) Cost of Revenue (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cost of Revenue for 10 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue fell 90.36% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $125.0 million (down 94.19% YoY), while the FY2026 annual figure was $134.1 million, up 72.71% from the prior year.
- Cost of Revenue fell to $6.0 million in Q1 2026 per ACB's latest filing, from $34.4 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $5.1 billion in Q2 2023 and bottomed at $6.0 million in Q1 2026.
- Historically, Cost of Revenue has averaged $599.3 million across 5 years, with a median of $42.5 million in 2024.
- Annual changes were most pronounced in 2023 — Cost of Revenue soared 14137.49% — and 2024, when it slumped 99.21%.
- Aurora Cannabis' Cost of Revenue stood at $110.1 million in 2022, then sank by 70.8% to $32.2 million in 2023, then fell by 0.13% to $32.1 million in 2024, then rose by 7.2% to $34.4 million in 2025, then tumbled by 82.58% to $6.0 million in 2026.
- Business Quant data shows ACB's Cost of Revenue at $6.0 million in Q1 2026, $34.4 million in Q4 2025, and $39.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 34.44 Mn |
| Dec 31, 2025 | 34.44 Mn |
| Sep 30, 2025 | 39.77 Mn |
| Sep 30, 2025 | 39.77 Mn |
| Jun 30, 2025 | 44.79 Mn |
| Jun 30, 2025 | 44.79 Mn |
| Mar 31, 2025 | 62.20 Mn |
| Mar 31, 2025 | 62.20 Mn |
| Dec 31, 2024 | 32.12 Mn |
| Dec 31, 2024 | 32.12 Mn |
| Sep 30, 2024 | 2.02 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 40.17 Mn |
| Jun 30, 2024 | 40.17 Mn |
| Mar 31, 2024 | 15.65 Mn |
| Mar 31, 2024 | 15.65 Mn |
| Dec 31, 2023 | 32.17 Mn |
| Dec 31, 2023 | 32.17 Mn |